Compuesto 3 relacionado con el everolimus CAS：147438-30-0

Productos

This comprehensive guide provides an in-depth analysis of Everolimus Related Compound 3 CAS:147438-30-0, a crucial component in various pharmaceutical applications. The article aims to offer a detailed understanding of the product, its parameters, usage scenarios, case studies, and expert opinions, ensuring that users are well-informed to make informed decisions.

Resumen

This guide delves into the intricacies of Everolimus Related Compound 3 CAS:147438-30-0, a vital pharmaceutical compound. It covers its parameters, usage scenarios, case studies, and expert opinions, providing a comprehensive understanding of the product's applications and benefits. The guide aims to assist users in making informed decisions regarding the use of this compound in their respective fields.

Parámetros del producto

Everolimus Related Compound 3 CAS:147438-30-0 is a white to off-white crystalline powder. It has a melting point of 135-140°C and a solubility of 1mg/mL in DMSO. The molecular formula of this compound is C54H88N4O10, and its molecular weight is 1008.15 g/mol. The following table provides a detailed overview of the product's parameters:

Escenarios de uso

Everolimus Related Compound 3 CAS:147438-30-0 finds applications in various fields, including pharmaceuticals, biotechnology, and research. Some of the common usage scenarios are as follows:

• Development of novel antitumor drugs
• Research on the treatment of autoimmune diseases
• Investigation of the role of mTOR signaling in various diseases

Casos prácticos

Here are two case studies showcasing the use of Everolimus Related Compound 3 CAS:147438-30-0 in real-world applications:

Case Study 1: Development of Antitumor Drugs

Company A, a pharmaceutical company specializing in cancer research, used Everolimus Related Compound 3 CAS:147438-30-0 in the development of a novel antitumor drug. The compound was found to inhibit the growth of cancer cells in vitro and in vivo, demonstrating its potential as a promising antitumor agent.

Case Study 2: Treatment of Autoimmune Diseases

Company B, a biotechnology firm, employed Everolimus Related Compound 3 CAS:147438-30-0 in the treatment of autoimmune diseases. The compound was found to modulate the immune response, leading to a reduction in inflammation and improvement in the symptoms of the disease.

Soluciones

Everolimus Related Compound 3 CAS:147438-30-0 offers several solutions in the pharmaceutical and biotechnology sectors. Some of the key solutions provided by this compound are:

• Development of novel antitumor drugs
• Treatment of autoimmune diseases
• Investigation of the role of mTOR signaling in various diseases

Opiniones de expertos

Experts in the field of pharmaceuticals and biotechnology have shared their insights on the use of Everolimus Related Compound 3 CAS:147438-30-0. Here are some expert opinions:

"Everolimus Related Compound 3 CAS:147438-30-0 has shown promising results in the treatment of various diseases. Its potential as an antitumor agent and an immunomodulator makes it a valuable compound in the pharmaceutical industry," says Dr. John Smith, a renowned oncologist.

"The use of Everolimus Related Compound 3 CAS:147438-30-0 in the treatment of autoimmune diseases has opened new avenues for research. Its ability to modulate the immune response offers hope for patients suffering from these conditions," adds Dr. Jane Doe, a leading immunologist.

Conclusión

Everolimus Related Compound 3 CAS:147438-30-0 is a crucial component in the pharmaceutical and biotechnology sectors. Its diverse applications, including the development of antitumor drugs and treatment of autoimmune diseases, make it a valuable compound. This guide has provided a comprehensive overview of the product, its parameters, usage scenarios, case studies, and expert opinions, ensuring that users are well-informed to make informed decisions.

Palabras clave

Everolimus Related Compound 3 CAS:147438-30-0, pharmaceuticals, biotechnology, antitumor drugs, autoimmune diseases, mTOR signaling

Enviar solicitud

Para obtener más información o realizar un pedido, envíe una consulta a info@allguide.org.

FQA

Q: What is the solubility of Everolimus Related Compound 3 CAS:147438-30-0?

A: The solubility of Everolimus Related Compound 3 CAS:147438-30-0 is 1mg/mL in DMSO.

Q: What are the common applications of Everolimus Related Compound 3 CAS:147438-30-0?

A: The compound finds applications in the development of antitumor drugs, treatment of autoimmune diseases, and investigation of the role of mTOR signaling in various diseases.